Abstract 189: Evaluation of Atrial Fibrillation Outcomes in Heart Failure Patients Taking Sacubitril/valsartan or Ivabradine

2019 
Background: Approximately 5.7 million adults have heart failure in the United States. No pharmacological breakthrough molecules have been developed for heart failure patients since angiotensin conv...
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []